BSE Live
Oct 29, 16:01Prev. Close
1625.65
Open Price
1617.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 29, 15:56Prev. Close
1628.40
Open Price
1628.40
Bid Price (Qty.)
1629.60 (18)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Eris Lifesciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 21.23 | 20.75 | 21.36 | 18.05 | 10.03 | |
| Diluted EPS (Rs.) | 21.21 | 20.74 | 21.36 | 18.05 | 10.03 | |
| Cash EPS (Rs.) | 24.76 | 23.05 | 22.94 | 19.61 | 11,414.35 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 95.72 | 84.06 | 63.14 | 41.79 | 22,126.96 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 95.72 | 84.06 | 63.14 | 41.79 | 22,126.96 | |
| Dividend / Share(Rs.) | 2.87 | 0.00 | 0.00 | 0.00 | 6,042.00 | |
| Revenue from Operations/Share (Rs.) | 75.14 | 65.19 | 55.32 | 51.85 | 43,875.58 | |
| PBDIT/Share (Rs.) | 27.27 | 26.63 | 25.03 | 21.54 | 12,579.35 | |
| PBIT/Share (Rs.) | 23.97 | 24.33 | 23.44 | 19.98 | 11,162.75 | |
| PBT/Share (Rs.) | 23.83 | 22.67 | 22.68 | 19.93 | 11,154.06 | |
| Net Profit/Share (Rs.) | 21.45 | 20.75 | 21.36 | 18.05 | 9,997.75 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 36.29 | 40.84 | 45.24 | 41.55 | 28.67 | |
| PBIT Margin (%) | 31.89 | 37.31 | 42.37 | 38.54 | 25.44 | |
| PBT Margin (%) | 31.71 | 34.77 | 41.00 | 38.43 | 25.42 | |
| Net Profit Margin (%) | 28.54 | 31.83 | 38.60 | 34.80 | 22.78 | |
| Return on Networth / Equity (%) | 22.41 | 24.68 | 33.82 | 43.18 | 45.18 | |
| Return on Capital Employed (%) | 24.40 | 28.35 | 27.79 | 46.11 | 41.69 | |
| Return on Assets (%) | 19.63 | 19.40 | 21.43 | 37.78 | 34.31 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.32 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 68.78 | 60.97 | 55.51 | 108.56 | 150.57 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.01 | 1.89 | 1.50 | 3.51 | 3.33 | |
| Quick Ratio (X) | 2.57 | 1.63 | 1.23 | 2.73 | 2.63 | |
| Inventory Turnover Ratio (X) | 15.59 | 12.00 | 13.22 | 15.10 | 12.24 | |
| Dividend Payout Ratio (NP) (%) | 13.37 | 0.00 | 0.00 | 0.00 | 60.21 | |
| Dividend Payout Ratio (CP) (%) | 11.59 | 0.00 | 0.00 | 0.00 | 52.74 | |
| Earnings Retention Ratio (%) | 86.63 | 0.00 | 0.00 | 0.00 | 39.79 | |
| Cash Earnings Retention Ratio (%) | 88.41 | 0.00 | 0.00 | 0.00 | 47.26 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 4,938.54 | 8,850.50 | 11,192.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 4.84 | 9.87 | 14.71 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 13.34 | 24.17 | 32.52 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 4.90 | 9.88 | 14.37 | 0.00 | 0.00 | |
| Retention Ratios (%) | 86.62 | 0.00 | 0.00 | 0.00 | 39.78 | |
| Price/BV (X) | 3.85 | 7.66 | 12.59 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 4.90 | 9.88 | 14.37 | 0.00 | 0.00 | |
| Earnings Yield | 0.06 | 0.03 | 0.03 | 0.00 | 0.00 |
25.08.2025
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
08.08.2025
06.08.2025
Buy Eris Lifesciences; target of Rs 1975: Prabhudas Lilladher
12.08.2025
Eris Life Consolidated June 2025 Net Sales at Rs 773.00 crore, up 7.4% Y-o-Y
05.08.2025
Eris Life Standalone June 2025 Net Sales at Rs 578.64 crore, up 26.7% Y-o-Y
20.05.2025
Eris Life Consolidated March 2025 Net Sales at Rs 705.30 crore, up 28.02% Y-o-Y
20.05.2025
Eris Life Standalone March 2025 Net Sales at Rs 404.77 crore, up 18.6% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher